About: OKYO Pharma Limited, a clinical-stage ophthalmology company, develops therapies for corneal and anterior diseases in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase 2 clinical trials for the treatment of dry eye disease and neuropathic corneal pain. The company is also developing OK-201 for the treatment of acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.45 (-5.23%)
OKYONASDAQOKYO Pharma Ltd ADR
OKYO Pharma Ltd ADR share price
OKYO price activity
Last Price
$1.450
Change (24hr)
-0.08 USD (-5.23%)
Volume
80.21K
Volume (4w avg)
-
Open
$1.53
Day Range
$1.39 - $1.53
Previous Close
$1.53
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
OKYO price performance
Delayed
09 Sep, 8:00 pm GMT+0
OKYO Market Signals